Four experiments were conducted to investigate the effects of ultraviolet (UV) light exposure and several cholecalciferol metabolites on the development of tibial dyschondroplasia (TD) and other parameters associated with vitamin D metabolism in chickens selected for high (HTD) and low (LTD) incidence of TD. In Experiment 1, exposure of chickens to UV light reduced the incidence and severity of TD more in LTD chickens than in HTD chickens, as evident by the significant interactions (P < 0.10 and 0.04). In Experiment 2, the addition of cholecalciferol to diets that were deficient in cholecalciferol linearly decreased the incidence of vitamin D rickets and increased bone ash, but increased the incidence of severe TD. The LTD chickens had a higher maximal bone ash of 40.0 ± 0.7% than did the HTD chickens, which had a maximal bone ash of 37.0 ± 0.7%. In Experiment 3, the addition of 5 mg/kg of 25-hydroxycholecalciferol [25-(OH)D 3 ], 1-ahydroxycholecalciferol, or 1,25-dihydroxycholecalciferol decreased the incidence and severity of TD in the LTD chickens and had no effect on TD in HTD chickens. In Experiment 4, increasing dietary 25-(OH)D 3 increased plasma 25-(OH)D 3 levels in both lines, but HTD chickens had higher plasma 25-(OH)D 3 levels at 20 and 40 mg/kg of dietary 25-(OH)D 3 . The incidence and severity of TD were reduced in the LTD chickens by dietary 25-(OH)D 3 , but little effect was noted in HTD chickens. The LTD chickens reached a maximal bone ash at 9.7 ± 1.9 mg/kg and HTD chickens reached the same bone ash at 33.0 ± 7.0 mg/kg. These results indicate that UV light and vitamin D metabolites are not effective in preventing TD in HTD chickens, but that altered vitamin D metabolism does exist between HTD and LTD chickens.
INTRODUCTION
Various dietary factors have been linked to the development of tibial dyschondroplasia (TD) in growing chickens. Diets marginal in Ca and high in P increase the occurrence of TD (Edwards and Veltmann, 1983) , whereas supplementation of these types of diets with 1,25-dihydroxycholecalciferol [1,25-(OH) 2 D 3 ] reduces the incidence (Edwards, 1989 (Edwards, , 1990 . Cholecalciferol derivatives without the 1-hydroxylation have shown variable results (Edwards, 1989) . Loften and Soares (1986) reported that elevated levels of cholecalciferol decrease the incidence of rickets but increased TD. Similar findings were noted by Elliot (1992) , who found that a cholecalciferol level up to 10 times the NRC (1994) requirement does not reduce the incidence of TD, whereas it strikingly reduces the incidence of rickets.
Ultraviolet (UV) light causes a photochemical reaction in the skin, in which 7-dehydrocholesterol is converted to vitamin D precursors and then to vitamin D (Holick, 1981) . Edwards et al. (1992) reported that chickens exposed to UV light had a reduced incidence and severity of TD. This report demonstrated that regardless of level of Ca or cholecalciferol, TD was significantly reduced by exposure to UV light.
The role of genetics in the development of TD has been evident since the lesion was first observed (Leach and Nesheim, 1965) . The success of commercial breeders in producing rapidly growing broilers likely plays a key role in the prevalence of TD in commercial flocks today. Chickens that have been divergently genetically selected for the incidence of TD, but that do not differ in growth rate, could serve as a useful model in understanding the mechanistic aspect of the development of the TD lesion and its control. To date, a very limited amount of research has been published using such lines in 1 Vitamin premix provided in milligrams per kilogram diet (except as noted): vitamin A (as all-trans-retinyl acetate), 1.9; cholecalciferol, 27.5 mg; vitamin E (all-rac-a-tocopheryl acetate), 11; riboflavin, 4.4; calcium pantothenate, 12; nicotinic acid, 44; choline Cl, 220; vitamin B 12 , 9 mg; vitamin B 6 , 3.0; menadione (as menadione sodium bisulfite), 1.1; thiamin (as thiamin mononitrate), 2.2; folic acid, 3; biotin, 0.3; and ethoxyquin, 125. 2 Trace mineral premix provided in milligrams per kilogram diet; MnO 2 , 222; ZnO, 150; FeSO 4 ·7H 2 O, 200; FeCO 3 , 83; CuSO 4 ·5H 2 O, 29; and Ca (IO 3 ) 2 , 15. 3 The analyzed values for the calcium and phosphorus content of the diets were: Experiment 1-0.75% Ca, 0.59% P; Experiment 2-1.16% Ca, 0.71% P; Experiment 3-0.98% Ca, 0.72% P; and Experiment 4-1.06% Ca, 0.70% P. nutrition-based experiments. The purpose of the present study is to examine the effects of UV light, cholecalciferol, and some of its metabolites on the development of TD and other bone characteristics using chickens genetically selected for high and low incidences of TD.
MATERIALS AND METHODS
Chicks of both sexes from flocks selected for seven or eight generations for a high incidence of TD (HTD) and a low incidence of TD (LTD) were used in all experiments (Wong-Valle et al., 1993) . Chicks were wingbanded and housed in electrically heated battery brooders 4 with wire mesh floors, with feed and water provided continuously. The temperature of the room was maintained at 22 C. The basal diet shown in Table 1 was used in all experiments except Experiment 2, in which the cholecalciferol was omitted. It was calculated to contain 1.0% Ca, 0.65% total P, and 1,100 IU of cholecalciferol unless otherwise noted. In Experiment 1, the analyzed Ca values were lower than calculated ones (0.75 vs 1.0%). The fluorescent lights used in the battery were General Electric, F15T8-CW, providing 3.4% of the watts in the ultraviolet range (260 to 400 nm). These lights were covered with plastic sleeves 5 to prevent exposure to UV light unless otherwise noted. A diagram of the configuration of the pen and light in relation to chick is described by Edwards et al. (1994) .
All experiments were conducted for 16 d. At termination of the experiment all the chicks were weighed by pen and their feed consumption was determined. They were all killed by carbon dioxide asphyxiation and randomized before growth plate examination. Tibial dyschondroplasia was determined using a 0 to 3 scoring system as described by Edwards and Veltmann (1983) . In Experiment 2, chickens with a lengthened growth plate were classified as having rickets from cholecalciferol deficiency. Bone ash, on a fat free dry weight basis, (Association of Official Analytical Chemists, 1995) was determined on the left tibia.
Experimental Design
Experiment 1 was conducted to determine the influence of UV light exposure in HTD and LTD chickens. Pens of chickens were exposed to UV light from the fluorescent lights detailed above in an arrangement described by Edwards et al. (1994) . These authors demonstrated that the use of plastic sleeves prevented exposure to UV light. Chickens were placed in pens with a sleeve covering the fluorescent light or with the light not covered. Six pens of 10 chickens each were subjected to each treatment. The experiment was analyzed as a 2 × 2 factorial with main effects of line and UV light (SAS Institute, 1990) .
Experiment 2 was conducted to determine the effect of levels of cholecalciferol in HTD and LTD chickens. The vitamin mixture in this experiment contained no cholecalciferol. Supplemental levels of cholecalciferol (0, 5, 10, 20, or 40 mg/kg) were added to the basal diet. Four pens of 10 chickens each were subjected to each treatment. The experiment was analyzed as a 2 × 5 factorial with genetic line and levels of cholecalciferol as main effects. Means were separated by Student-Newman-Keuls test where appropriate. Both simple and multiple regression analysis for levels of cholecalciferol were performed overall and on each line. Contrast for effects of each level of cholecalciferol and interactions for line and each level of cholecalciferol were compared to the basal diet (SAS Institute, 1990) . Nonlinear regression was performed on each line to find the maximum response and requirement for bone ash. (SAS Institute, 1990) . Experiment 4 was conducted to determine the effects of supplemental dietary 25-(OH)D 3 in HTD and LTD chicks. Four pens of 10 birds each of both lines were fed the basal diet alone or supplemented with 25-(OH)D 3 at levels of 5, 10, 20, and 40 mg/kg. The experiment was analyzed as a 2 × 5 factorial and regression analysis using levels of 25-(OH)D 3 in simple and multiple models was performed overall and on each line. Contrasts were compared to the basal diet for effects of each level of cholecalciferol and interactions for line and each level of 25-(OH)D 3 . Nonlinear regression was performed on each genetic line to find the amount of 25-(OH)D 3 to maximize bone ash (SAS Institute, 1990) .
Plasma Analysis
At termination of the experiments blood samples were taken from two birds per pen and the plasma was analyzed for total Ca 6 and dialyzable P. 7 In Experiment 4, blood from the two birds was obtained by cardiac puncture, the plasma pooled and used for determination of 1,25-(OH) 2 D 3 and 25-(OH)D 3 . Plasma was extracted by a dual-cartridge technique (Reinhart and Hollis, 1986) . A radioreceptor assay using receptors from intestines of chickens fed diets deficient in vitamin D (Eisman, et al., 1976; Horst, 1983) was used for determination of 1,25-(OH) 2 D 3 . The assay conditions were similar to those of Reinhart and Hollis (1986) except that incubation was performed at 4 C for 16 to 18 h. Plasma 25-(OH)D 3 was determined by HPLC analysis (Kao and Hesser, 1984) .
RESULTS

Experiment 1
Exposure to UV light increased BW, bone ash, and dialyzable P and decreased the incidence and severity of TD (Table 2) . Plasma Ca and feed efficiency was unaffected by UV light.
The incidence of TD was higher in the HTD chicks than in the LTD chicks (86 vs 35%; P ≤ 0.001) ( Table 2 ). The interaction between genetic line and UV light for TD approached significance (P ≤ 0.10). There was no effect of UV light on the overall incidence of TD in HTD chickens (87 to 85%), whereas it reduced the incidence from 51 to 18% in LTD chickens. Exposure to UV light reduced number three scores from 33 to 6% in the LTD chickens, but only from 64 to 50% in HTD chickens, resulting in a significant UV light by line interaction (P ≤ 0.04).
Experiment 2
Body weight was increased at 5 mg/kg of cholecalciferol; linear and quadratic effects were significant (Table  3) . Additional amounts of supplementation increased BW TABLE 3. Effects of cholecalciferol levels on 16-d BW, gain:feed ratio, bone ash, plasma calcium and dialyzable phosphorus, incidence and severity of tibial dyschondroplasia, and incidence of rickets in high incidence (HTD) and low incidence (LTD) chickens, Experiment 2 1 1 Values are means of 4 pens per treatment for the line and cholecalciferol levels. Values are, therefore, means of 20 pens for the line main effects and 8 pens for the cholecalciferol levels main effects. Each pen initially contained 10 chickens that were used to obtain all of the above means except plasma Ca and P, where 2 chickens per pen were used to obtain the pen means. to some degree but the means were not significantly different than at 5 mg/kg. There were no genetic line differences in BW. The LTD chickens had higher gain:feed ratios in this experiment than HTD chickens (0.694 vs 0.634 g:g; P ≤ 0.02). Cholecalciferol supplementation did not significantly affect gain:feed ratio.
16-d BW
Cholecalciferol supplementation increased bone ash in a linear fashion up to 20 mg/kg (Table 3) but there were no genetic line differences between the means. The LTD chicks had a higher maximum bone ash than HTD chicks (Figure 1 ). Nonlinear regression analysis showed that LTD chickens reached a maximal bone ash of 40.0 ± 0.7% at a cholecalciferol level of 29.5 ± 3.7 mg/kg and the HTD chickens achieved a maximum bone ash of 37.2 ± 0.7% at a cholecalciferol of 20.8 ± 4.1 mg/kg.
Cholecalciferol supplementation at 5 mg/kg increased plasma Ca; however, there were no significant differences between the means when higher cholecalciferol was in the diet (Table 3 ). The LTD chickens had significantly higher plasma P than HTD chicks (5.3 vs 4.5; P ≤ 0.03). There was a significant cubic relationship between plasma P and cholecalciferol levels in both lines. Plasma P levels fell TABLE 4. Effects of cholecalciferol metabolites on 16-d BW, gain:feed ratio, bone ash, plasma calcium and dialyzable phosphorus, and incidence and severity of tibial dyschondroplasia in high incidence (HTD) and low incidence (LTD) chickens, Experiment 3 1 1 Values are means of 4 pens per treatment for the line and cholecalciferol derivative treatments. Values are, therefore, 20 pens for the line main effects and 8 pens for the cholecalciferol derivative main effects. Each pen initially contained 12 chickens that were used to obtain all of the above means except plasma Ca and P, where 2 chickens per pen were used to obtain the pen means.
2 All cholecalciferol metabolites were fed at a level of 5 mg/kg diet. with the addition of 5 and 10 mg/kg but were significantly greater at 20 and 40 mg/kg than at 0 mg/kg. The incidence and severity of TD was increased by cholecalciferol supplementation (Table 3 ). The overall incidence of TD and average score was higher at 5 mg/kg and the incidence of number three scores was higher at 10 mg/kg (Table 3) , but there were no significant differences in these criteria above these levels ( Table 3 ). The HTD chickens did have higher incidence of TD and number three scores than the LTD chickens (P ≤ 0.05). Rickets were decreased in both lines by increasing levels of cholecalciferol in a linear fashion until 40 mg/kg. There were no differences in the incidence of rickets between HTD and LTD chickens.
Experiment 3
There were no significant treatment effects on BW, gain:feed ratio, or plasma Ca (Table 4) . Supplementation with 24R,25-(OH) 2 D 3 had no effect on any criteria measured. There were significant line by 25-(OH)D 3 and 1a-(OH)D 3 interactions for bone ash (Table 4) . Supplementation with 25-(OH)D 3 or 1a-(OH)D 3 resulted in large increases in bone ash of LTD chickens, but not of the HTD chickens. These supplements did not improve bone ash in HTD chicks to the extent as in LTD chicks. Bone ash was increased by 1,25-(OH) 2 D 3 in both lines. Plasma dialyzable P was not affected by genetic line but was increased by dietary 25-(OH)D 3 or 1,25-(OH) 2 D 3 .
Supplementation with 1,25-(OH) 2 D 3 decreased the incidence of TD and number three scores, whereas the addition of 25-(OH)D 3 and 1a-(OH)D 3 only reduced the incidence of number three scores (Table 4 ). There were genetic line by supplement interactions for 25-(OH)D 3 , 1,25-(OH) 2 D 3 , and 1a-(OH)D 3 for the incidence of TD and number three scores (Table 4 ). These supplements reduced the incidence of TD and number three scores in the LTD chicks but were without effect in HTD chickens. 
Experiment 4
The lowest level of 25-(OH)D 3 tested increased BW in both lines of chickens. Additional amounts of the supplement did not cause any further increases in BW (Table 5 ). There were no genetic line differences in BW and no diet or line effects on feed efficiency.
Tibia bone ash was increased in a dose-related manner by dietary 25-(OH)D 3 (Table 5 ). The LTD chickens had higher bone ash at 5 and 10 mg/kg than HTD chickens, resulting in an interaction between genetic line and 25-(OH)D 3 at these levels (P ≤ 0.07 and 0.01). Maximal bone ash of 39.9 ± 0.7% for the HTD line and 40.0 ± 0.7% for LTD line were similar, but the amount of 25-(OH)D 3 to reach this amount was different (Figure 2 ). The LTD chickens reached maximal bone ash at 9.7 ± 1.9 mg/kg and HTD chickens achieved maximal bone ash at 33.0 ± 7.0 mg/ kg.
The regression analysis for plasma P on each line showed no significant linear response, although the combined data analysis showed that it increased with increasing levels of 25-(OH)D 3 (Table 5) The addition of dietary 25-(OH)D 3 reduced the incidence of TD in the LTD chickens and had no effect in HTD chickens resulting in interactions at 20 and 40 mg/kg (P ≤ 0.06 and 0.02; Table 5 ). The supplementation of 25-(OH)D 3 reduced the incidence of number three scores; however, the reduction in the HTD was not to the extent that it was in the LTD chickens, resulting in an interaction between genetic line and dietary 25-(OH)D 3 .
DISCUSSION
These experiments demonstrate that exposure to UV light or dietary supplementation with cholecalciferol metabolites does not prevent the occurrence of TD in the HTD line of chicken. It is also evident that there are some differences in cholecalciferol metabolism between the HTD and LTD chickens.
The role of vitamin D in bone development is well known and for the most part well understood. A deficiency in cholecalciferol leads to a rachitic condition characterized by a lengthening of the proliferating zone of the growth plate (Long et al., 1984) . Exposure to UV light decreases the incidence of rickets in chickens with a cholecalciferol deficiency and reduces TD in chickens that are sufficient in cholecalciferol (Edwards et al., 1992; Elliot, 1992) . Exposure of HTD chickens to UV light did not reduce the overall incidence of TD, but it slightly reduced the incidence of number three scores. The LTD chickens subjected to UV light had a sharply reduced incidence of TD and number three scores. The HTD chickens responded similarly to LTD chicks to UV light exposure when bone ash and plasma dialyzable P were the criteria measured. This result indicates that although UV light is effective as a source of vitamin D in HTD chickens, the TD lesion in these chickens does not respond to vitamin D given in this manner.
Sheep exposed to UV light have higher plasma levels of cholecalciferol and 25-(OH)D 3 than those given oral cholecalciferol supplements of 50 mg/d (Hidiroglou and Karpinski, 1989) . Birds given no dietary cholecalciferol but exposed to UV light grow identically to and have bone and tissue characteristics similar to those of birds given 20 or 40 mg/kg of dietary cholecalciferol . In LTD chickens, high levels of oral vitamin D did not reduce the prevalence of TD, whereas exposure to UV light in LTD chickens was effective in reducing the incidence of TD, even though the birds received adequate dietary vitamin D. The results of the present study and those noted by Edwards et al. (1992 Edwards et al. ( , 1994 indicate that UV light results in animal responses similar to those ascribed to vitamin D but greater than can be obtained from oral cholecalciferol. Serum 1,25-(OH) 2 D 3 levels increase in vitamin D-deficient patients when they are exposed to UV light, although little change in these levels was noted in normal patients given the same treatment (Adams et al., 1982) . There is no other evidence to suggest that circulating 1,25-(OH) 2 D 3 is significantly affected by UV light exposure in animals with sufficient vitamin D. Plasma 25-(OH)D 3 increases when animals are exposed to UV light (Adams et al., 1982; Hidiroglou and Karpinski, 1989) . The effects of the UV light in Experiment 1 are comparable to those of dietary 25-(OH)D 3 in Experi- Effects of 25-hydroxycholecalciferol on 16-d BW, gain:feed ratio, bone ash, plasma calcium, dialyzable phosphorus, 25-hydroxycholecalciferol, and 1,25-dihydroxycholecalciferol, and incidence and severity of tibial dyschondroplasia in high incidence (HTD) and low incidence (LTD) chickens, Experiment 4 1 1 Values are means of 4 pens per treatment for the line and 25-(OH)D 3 levels. Values are, therefore, means of 20 pens for the line main effects and 8 pens for the 25-(OH)D 3 levels main effects. Each pen initially contained 10 chickens which were used to obtain all of the above means except plasma Ca and P (2 chickens per pen) and plasma 25-(OH)D 3 and 1,25-(OH) 2 D 3 (one pooled sample from 2 chickens per pen).
2 Probability values shown for most appropriate model as determined by R 2 . (Holick, 1981) , whereas oral vitamin D enters the system by way of DBP and the portomicrons from the intestines (Combs, 1992) . The discrepancy in binding proteins may explain some of the difference in effectiveness of oral vitamin D and that produced by exposure to UV irradiation. Lofton and Soares (1986) and Elliot (1992) reported that as the levels of cholecalciferol increased in the diet the number of birds with rickets decreased but the incidence of TD increased. In Experiment 2, the incidence of rickets decreased in a linear fashion with increasing dietary levels of cholecalciferol in both lines. The incidence of TD increased in response to dietary cholecalciferol. This effect may be associated with the higher growth rate in birds supplemented with cholecalciferol. These results suggest that although cholecal-ciferol can prevent rickets it does not prevent TD, whereas the 1-hydroxylated derivatives prevent both (Edwards, 1989 (Edwards, , 1990 .
Perhaps more important is the response of bone ash in the two lines to dietary cholecalciferol. The HTD chickens reach a lower maximal bone ash than the LTD chickens (Figure 1 ). It would seem that even with high levels of cholecalciferol in the diet, the ability to put mineral in the bone is somewhat impaired in HTD chickens. This observation is contrary to previous findings because no differences in bone ash between birds with the dyschondroplasia lesion and normal birds have been noted (Leach and Lilburn, 1992) .
The addition of 1,25-(OH) 2 D 3 to diets marginal in Ca and high in P reduces TD in broiler chickens (Edwards, 1989 (Edwards, , 1990 . Previous work has also shown that 5 mg/kg of 1,25-(OH) 2 D 3 was moderately effective and 10 mg/kg of the metabolite was maximally effective in preventing TD in chickens, from different genetic stock than the chickens used in the present studies, selected for a high occurrence of TD (Thorp et al., 1993) . In Experiment 3, supplementation with 5 mg/kg of 1,25-(OH) 2 D 3 or 1a-(OH)D 3 failed to reduce the incidence or severity of TD in the HTD chicks. The contradictory nature of the present work and that of Thorp et al. (1993) shows the effectiveness of the 1-a(OH)D 3 derivatives in preventing TD in HTD chicks needs more attention.
Dietary 25-(OH)D 3 is reported to give only variable results for preventing TD (Edwards, 1989) . In both Experiments 3 and 4, it decreased the incidence and severity of TD in the LTD chicks. However, no effect is noted in Experiment 3 and little effect is noted in Experiment 4 for the HTD chickens. The effects of dietary 25-(OH)D 3 in LTD chickens warrants further investigation into the ability of this compound to prevent TD in commercial broilers. The recent commercial availability of 25-(OH)D 3 has renewed interest in this metabolite as an alternative to cholecalciferol (Yarger et al., 1995) . These authors used a basal level of 69 mg 25-(OH)D 3 /kg of feed in their study when 25-(OH)D 3 was used as the only source of vitamin D. The present study found that 10 mg/kg is adequate to achieve maximal bone ash and decreased incidence of TD in LTD chickens when the diet contains 27.5 mg/kg cholecalciferol.
In both Experiments 3 and 4, there are line by 25-(OH)D 3 interactions for bone ash. The HTD chickens have no bone ash response to 5 mg/kg of 25-(OH)D 3 in Experiment 3. In Experiment 4, both lines have a similar maximal bone ash, but it took vastly different levels of 25-(OH)D 3 to reach these levels (Figure 2 ). This result is in contrast to Experiment 2, in which LTD chickens reached a higher maximal bone ash than HTD chickens at 40 mg/kg of cholecalciferol. It might be assumed that the vitamin is not being absorbed properly in the HTD chicks; however, plasma levels of 25-(OH)D 3 are higher in the HTD chicks than in the LTD chicks at the higher levels of dietary 25-(OH)D 3 . Elliot and Edwards (1994) hypothesized that young rapidly growing broilers could not produce adequate amounts of 1,25-(OH) 2 D 3 , which may leave them vulnerable to the development of TD. These researchers found that strains with the highest susceptibility to TD had the highest levels of plasma 1,25-(OH) 2 D 3 . This disproved their hypothesis that TD is caused by a deficiency in 1,25-(OH) 2 D 3 . No significant genetic line differences were noted for plasma 1,25-(OH) 2 D 3 in the present study, although the observation that high levels of dietary 25-(OH)D 3 (20 and 40 mg/kg) decreased plasma 1,25-(OH) 2 D 3 is interesting.
The high incidences of TD in the LTD chicks in some of the experiments is troubling. This probably speaks to the many factors that influence TD that are either unknown or uncontrolled. The low Ca diet inadvertently fed in Experiment 1 would cause an increase in TD; however, the other diets contained appropriate levels of Ca and P. One possible explanation is the brooding facilities. During the selection process, birds are raised on the floor (Wong-Valle et al., 1993) . In our experiments, the birds are reared in battery brooders with wire floors. Whether this contributes to the higher than expected incidence of TD in the LTD line is only speculation. It does certainly show that even though broilers can be selected for a lower or higher occurrence of TD (Wong-Valle et al., 1993) , these divergently selected lines can be susceptible to some of the same environmental or dietary factors that causes the TD lesion to form in unselected stock.
It is evident that there are differences in vitamin D metabolism between lines selected for divergent genetic tendencies for TD. Because plasma levels of the vitamin D metabolites are equal or higher in the HTD than in the LTD line, there may be alterations in receptor concentration. Soares et al. (1990) found a trend of lower vitamin D receptors in the intestinal mucosal and the growth plate in birds with a high genetic tendency for TD. This finding may explain the higher amounts of 25-(OH)D 3 needed to reach maximal bone ash and the inability to reach a high bone ash even with high levels of cholecalciferol in HTD chickens.
